Show simple item record

dc.contributor.advisorHutt, Peter Bartonen_US
dc.contributor.authorKang, Brianen_US
dc.date.accessioned2012-06-07T20:42:12Z
dc.date.issued2003en_US
dc.identifier.citationWESTERN STATES MEDICAL AND OTHER PROBLEMS WITH THE DOCTRINE CONCERNING FDA REGULATION OF COMMERCIAL SPEECH (2003 Third Year Paper)en
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:8852194
dc.description.abstractThis paper will attempt to explain the current state of how commercial speech doctrine affects FDA regulation by looking closely to a recently decided case: Thompson v. Western States Medical. This case will then be used as platform from which to critique current commercial speech doctrine and suggest changes. This paper will then turn to other recent developments in the law, both in caselaw and legal scholarship, which may have profound effects on how we think about commercial speech.en
dc.language.isoen_USen
dash.licenseLAAen_US
dc.subjectFood and Drug Lawen
dc.subjectcommercial speechen
dc.subjectfree speechen
dc.subjectregulationen
dc.subjectFirst Amendmenten
dc.titleWESTERN STATES MEDICAL AND OTHER PROBLEMS WITH THE DOCTRINE CONCERNING FDA REGULATION OF COMMERCIAL SPEECHen
dc.typePaper (for course/seminar/workshop)en_US
dc.date.available2012-06-07T20:42:12Z
dash.authorsorderedfalse


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record